Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Engineering small molecule specificity in nearly identical cellular environments.

Mark A Sellmyer1, Kryn Stankunas, Roger Briesewitz

  • 1Department of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, USA.

Bioorganic & Medicinal Chemistry Letters
|March 27, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BACH2 regulates T cell lineage state to enhance CAR T cell function.

Nature immunology·2026
Same author

Design and Development of DNA Damage Chemical Inducers of Proximity for Targeted Cancer Therapy.

Journal of the American Chemical Society·2026
Same author

Influence of Subcellular Localization on the Cytotoxicity of Targeted α-Therapy.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same author

Photocontrolled trimethoprim PROTACs targeting the eDHFR protein tag.

Nature communications·2025
Same author

Residual Breast Cancer Cells Co-opt SOX5-Driven Endochondral Ossification to Maintain Dormancy.

Cancer discovery·2025
Same author

Voltage-gated calcium channels generate blastema Ca2+ fluxes restraining zebrafish fin regenerative outgrowth.

Development (Cambridge, England)·2025
Same journal

Solid-phase synthesis and antimicrobial activities of lipid-neomycin conjugates.

Bioorganic & medicinal chemistry letters·2026
Same journal

Discovery of a potent sGC stimulator with once-daily dosing potential for the treatment of hypertension.

Bioorganic & medicinal chemistry letters·2026
Same journal

OracleScreen-LILRB4 (HTS-Oracle v3): machine learning-guided discovery of myeloid immune checkpoint binders validated in patient-derived cells.

Bioorganic & medicinal chemistry letters·2026
Same journal

Rational design and N-terminal acylation of a lactam-cyclized 11-residue antimicrobial peptide for improved antibacterial potency.

Bioorganic & medicinal chemistry letters·2026
Same journal

Rational design, synthesis, and biological evaluation of chalcone hybrids including benzoylpiperazin (phenylacetylpiperazin)-thiophene as anti- Alzheimer's agents.

Bioorganic & medicinal chemistry letters·2026
Same journal

New aminopiperidine-azoles as antifungal agents against Candida albicans with mechanistic insights into the cAMP-PKA pathway.

Bioorganic & medicinal chemistry letters·2026
See all related articles

Researchers created a molecule that targets enzymes. This molecule

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Methotrexate (MTX) is a dihydrofolate reductase inhibitor.
  • FKBP12 is a protein that can bind to ligands.
  • Bifunctional molecules can have complex biological activities.

Purpose of the Study:

  • To create a bifunctional molecule (MTXSLF) by tethering MTX to an FKBP12 ligand (SLF).
  • To investigate the enzyme inhibition properties of MTXSLF.
  • To assess the cytotoxicity of MTXSLF in cells with and without FKBP12.

Main Methods:

  • Chemical synthesis of the bifunctional molecule MTXSLF.
  • Enzyme inhibition assays to determine specificity.
  • Cell-based assays using fibroblasts from FKBP12-null and wild-type mice.

Related Experiment Videos

Main Results:

  • MTXSLF potently inhibits either dihydrofolate reductase or FKBP12, but not both simultaneously.
  • MTXSLF is cytotoxic to FKBP12-null fibroblasts.
  • FKBP12 in wild-type fibroblasts detoxifies MTXSLF 40-fold, reducing its cytotoxicity.

Conclusions:

  • Non-target proteins can be leveraged to predictably regulate the biological activity of synthetic molecules.
  • FKBP12 acts as a detoxification mechanism for MTXSLF.
  • This strategy allows for targeted biological activity modulation based on genetic background.